Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

PDL Biopharma 10%+ Owner Edward Mule Reported Purchase of 2,090,000 Shares @ Avg Price of $2.57/Share in Form 4 Filing on Tuesday

Author: Charles Gross | December 16, 2020 06:57am

Posted In: PDLI